PRESS RELEASE published on 06/22/2026 at 15:24, 2 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 4.97% interest in Beazley plc. Details of securities holding and recent dealings provided Securities Disclosure The Vanguard Group Dealings Beazley Plc
PRESS RELEASE published on 06/22/2026 at 15:23, 2 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses 5.29% stake in LondonMetric Property plc and 0.94% in Schroder Real Estate Investment Trust Limited as of 19 June 2026 LondonMetric Property Plc Vanguard Group Stake Disclosure Financial Holdings Schroder Real Estate
BRIEF published on 06/19/2026 at 14:52, 2 months 24 days ago The Vanguard Group Discloses Stake in Schroders plc Form 8.3 Takeover Code Schroders Plc Vanguard Group Investment Disclosure
BRIEF published on 06/19/2026 at 14:49, 2 months 24 days ago The Vanguard Group Discloses Position in Forward Industries Disclosure Vanguard Group Shareholding Irish Takeover Rules Forward Industries
PRESS RELEASE published on 06/19/2026 at 14:47, 2 months 24 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.57% stake in Schroders plc on 18 June 2026. Purchase of 20p ordinary securities at 5.84 GBP per unit Schroders Plc Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase
BRIEF published on 06/19/2026 at 14:45, 2 months 24 days ago The Vanguard Group Discloses Position in Beazley plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Beazley Plc
PRESS RELEASE published on 06/19/2026 at 14:44, 2 months 24 days ago Form 8.3 - The Vanguard Group, Inc.: Forward Industries Inc. The Vanguard Group, Inc. discloses 3.14% ownership in Forward Industries Inc. with 2,318,865 ordinary shares. Dealings include purchase and sale of $0.01 ordinary shares The Vanguard Group Ownership Disclosure Dealings $0.01 Ordinary Shares Forward Industries Inc.
PRESS RELEASE published on 06/19/2026 at 14:40, 2 months 24 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.02% stake in Beazley plc through Form 8.3 filing on 18 June 2026 Form 8.3 The Vanguard Group Financial Disclosure Stake Disclosure Beazley Plc
BRIEF published on 06/18/2026 at 15:32, 2 months 25 days ago Vanguard Discloses Position in Tate & Lyle plc Takeover Code Vanguard Group Shareholding Form 8.3 Disclosure Tate & Lyle
BRIEF published on 06/18/2026 at 15:31, 2 months 25 days ago The Vanguard Group Reports Stake in Spire Healthcare Takeover Code Vanguard Group Public Disclosure Spire Healthcare Securities Position
Published on 09/12/2026 at 02:35, 1 day 16 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 20 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 21 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 1 hour ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 11 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 20 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 20 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 23 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 23 hours ago Availability of the 2026 Interim Financial Report
